Why the study?
Differentiating the cause of left ventricular hypertrophy is challenging with co-existing hypertension, prompting investigation into whether CMR parameters can distinguish hypertensive cardiomyopathy from cardiac amyloidosis in patients with hypertension and heart failure.
Does CMR differentiate hypertensive cardiomyopathy from cardiac amyloidosis in patients with hypertension and heart failure?
Does CMR differentiate hypertensive cardiomyopathy from cardiac amyloidosis in patients with hypertension and heart failure?
Extensive subendocardial LGE and elevated ECV are not pathognomonic for cardiac amyloidosis and can be seen in hypertensive cardiomyopathy, particularly in African American patients.
Answers are grounded in this paper and cite their sources.
Subendocardial LGE and ECV elevation overlap in HC and CA; leaves open reliable CMR differentiation in hypertensive heart failure.
PURPOSE: Differentiation of the cause of left ventricular hypertrophy (LVH) is challenging in cases with co-existing hypertension. CMR offers assessment of diffuse myocardial abnormalities via T1 mapping with extracellular volume fraction (ECV) and macroscopic fibrosis via late gadolinium enhancement imaging (LGE). The goal of the study was to understand if CMR parameters can differentiate hypertensive cardiomyopathy (HC) from cardiac amyloidosis (CA) in patients with hypertension and heart failure, using endomyocardial biopsy (EMB) as the gold standard. METHODS: We retrospectively analyzed patients with hypertension, LVH, and heart failure undergoing EMB due to uncertain diagnosis. CMR parameters including cine, LGE characteristics, T1 mapping, and ECV were analyzed. RESULTS: A total of 34 patients were included (mean age 66.5 ± 10.7 years, 79.4% male). The final EMB-based diagnosis was HC (10, 29%), light chain (AL) CA (7, 21%), and transthyretin (ATTR) CA (17, 50%). There was a significant difference in subendocardial LGE (p = 0.03) and number of AHA segments with subendocardial LGE (p = 0.005). The subendocardial LGE pattern was most common in AL-CA (85.7%) and African American with HC (80%). ECV elevation (≥ 29%) was present in all patients with CA (AL-CA: 57.6 ± 5.2%, ATTR-CA: 59.1 ± 15.3%) and HC (37.3 ± 4.5%). CONCLUSIONS: Extensive subendocardial LGE pattern is not pathognomonic for CA but might also be present in African American patients with longstanding or poorly controlled HTN. The ECV elevation in HC with HF might be more significant than previously reported with an overlap of ECV values in HC and CA, particularly in younger African American patients.
No takes yet. Share an insight, caveat, or question.
Gil et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: